Panel Discussion

Monday, March 10, 2025

3:54 PM – 4:10 PM ET

Panel Moderator(s)

Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

Disclosure(s): No financial relationships to disclose
John M. Lasala, MD, PhD, MSCAI

Professor of Medicine; Director, Structural Heart Disease Program
Washington University School of Medicine
St. Louis, Missouri, United States

Disclosure(s): Abiomed;: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Edwards, Abbott: Consultant (Ongoing); Shockwave Medical, Inc.: Consultant (Ongoing); W. L. Gore: Consultant (Ongoing)

Panel Discussant(s)

Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

Professor of Medicine
New York University School of Medicine
New York University School of Medicine
New York, New York, United States

Disclosure(s): Abbott Vascular, Boston Scientific, Biotronik, Inari, Imperative Care, Argon, Recor, Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing)
Florim Cuculi, MD

Head of Cardiology
Heart Center Lucerne, Luzern, Switzerland

Disclosure(s): No financial relationships to disclose
Stephen G. Ellis, MD, FACC, FSCAI

Director of Interventional Cardiology, Senior Academic Officer
Cleveland Clinic
Beachwood, Ohio, United States

Disclosure(s): No financial relationships to disclose
Adnan Kastrati, MD

Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): No financial relationships to disclose
Ramzi Khamis, MD PhD

Consultant Cardiologist. Clinical Director of Cardiology and Cardiothoracic Surgery
Imperial College London and Imperial College Healthcare NHS Trust
London , England, United Kingdom

Disclosure information not submitted.
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

Disclosure information not submitted.
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)
Ting-Yu Wang, MD

Cardiology Fellow, Division of Cardiovascular Diseases
Scripps Clinic
La Jolla, California, United States

Disclosure(s): No financial relationships to disclose
David X. Zhao, MD

Chief of Cardiovascular Medicine; Executive Director of Heart and Vascular Center
Atrium Health - Wake Forest Baptist
Winston Salem, North Carolina, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Maurice Buchbinder, MD, FSCAI: No financial relationships to disclose

John M. Lasala, MD, PhD, MSCAI: Abiomed;: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Edwards, Abbott: Consultant (Ongoing); Shockwave Medical, Inc.: Consultant (Ongoing); W. L. Gore: Consultant (Ongoing)

Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI: Abbott Vascular, Boston Scientific, Biotronik, Inari, Imperative Care, Argon, Recor, Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing)

Florim Cuculi, MD: No financial relationships to disclose

Stephen G. Ellis, MD, FACC, FSCAI: No financial relationships to disclose

Adnan Kastrati, MD: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Ting-Yu Wang, MD: No financial relationships to disclose

David X. Zhao, MD: No financial relationships to disclose